5-Amino-1MQ
Examine 5-Amino-1MQ research on NNMT, mouse metabolism, diet combinations and off-target effects, with clear limits on human weight-loss claims.
Read research profile ↗
Get the guide ↗Research questions, reported findings, and evidence limits.
78 matching profiles
Examine 5-Amino-1MQ research on NNMT, mouse metabolism, diet combinations and off-target effects, with clear limits on human weight-loss claims.
Read research profile ↗Evaluate Adamax identity and modified-Semax claims, separating related research and name collisions from direct evidence for the exact peptide.
Read research profile ↗Review Adipotide vascular-targeting research, monkey fat-loss findings, kidney injury and the terminated human trial without inventing its outcomes.
Read research profile ↗Explore AICAR exercise-mimetic research, AMPK-independent effects and the negative RED-CABG acadesine trial, with study-specific evidence limits.
Read research profile ↗Examine AOD-9604 human obesity results, animal fat-metabolism studies, GH fragment identity, safety reporting and joint-repair claims.
Read research profile ↗Review the triple blend through AOD-9604 animal and human evidence, CJC identity questions and the direct comparisons needed for metabolic claims.
Read research profile ↗Review ARA-290 and cibinetide human neuropathy studies, corneal nerve measurements, pain outcomes and safety findings with evidence limits.
Read research profile ↗Review BPC-157 tendon experiments, human knee-pain reports, the two-person safety pilot and FDA findings, with clear limits on clinical claims.
Read research profile ↗Evaluate direct rat combination evidence, limited human knee observations, TB-500 identity and finished-formulation questions for the BPC-157 blend.
Read research profile ↗Explore cagrilintide biology, monotherapy weight-loss findings, newer diabetes research, tolerability and the distinction from CagriSema combination results.
Read research profile ↗Review CagriSema weight-loss and diabetes trials, component comparisons, the missed REDEFINE 4 target, safety findings and current research status.
Read research profile ↗Review Cardiogen rat heart-explant and histone-binding studies, distinguishing tissue growth and proposed mechanisms from clinical cardiac benefit.
Read research profile ↗Review AED and T-31 research in renal cultures, chondrocytes and human stem cells, separating cartilage markers from proven joint repair.
Read research profile ↗Compare CARS, CASTA and CERE-LYSE findings, distinguishing early recovery signals, primary endpoints, rehabilitation context and preparation identity.
Read research profile ↗Examine Chonluten immune-cell signaling and inflammatory findings, including context-dependent responses and the limits of respiratory treatment claims.
Read research profile ↗Compare related GHRH and GHRP-2 human experiments, clarifying why hormonal interaction does not validate an unspecified CJC-1295 blend.
Read research profile ↗Explore CJC-1295 DAC human research, GH and IGF-1 findings, formulation differences, FDA safety concerns and the limits of claimed physical benefits.
Read research profile ↗Separate CJC-1295 DAC and ipamorelin component studies from exact-stack evidence, including a rat muscle study that did not test the pair.
Read research profile ↗